Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion type Assertion NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_head.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion description "[Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_provenance.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion evidence source_evidence_literature NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_provenance.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion SIO_000772 18191202 NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_provenance.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion wasDerivedFrom befree-20140225 NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_provenance.
- NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_assertion wasGeneratedBy ECO_0000203 NP313645.RAHb9CTVrHbF3UV4WyfiVzuE68G_fPmUDPlXppSOmjTbI130_provenance.